BioCryst is profitable. Now it wants to buy more rare disease drugs
CNBC · 15 days ago
Rare disease drug development is getting a boost from new funding models and a growing group of smaller biotech buyers.
Continue reading at CNBC →Social Justice News — https://social-justice.news/story/biocryst-is-profitable-now-it-wants-to-buy-more-rare-disease-drugs-41e1638e
● BreakingInfluencers are urging Home Depot and Lowe's to drop FlockImmigration
View all →
Latest
Loss of legal immigrant caregivers puts America's seniors at risk
The Hill · 43 minutes ago
Iran Push To Control World Oil Indicated By Pipeline Attack
Newsweek · 44 minutes ago
Missouri coach blasts Kansas over slavery references after Border War win
The Guardian · 46 minutes ago
Surrogate who fled to Texas to avoid abortion appeals custody case to Supreme Court
The Hill · 50 minutes ago
Saudi Arabia has few options as it faces mounting threats from Iran and its allies
PBS News · 51 minutes ago
Trump sparks speculation with strange claim about Don Jr: 'Code for something?'
The Raw Story · 1 hour ago
Ted Cruz Pushed His College Sports Bill on ESPN—and Was Booed Mercilessly
Mother Jones · 1 hour ago
Lopez: Abandoned properties, fire hazards. Are L.A. mayor candidates part of the fix, or the problem?
Los Angeles Times · 1 hour ago
